INTRODUCTION {#SEC1}
============

The structure of an RNA determines its interactions and functions ([@B1],[@B2]). RNA structure can be studied using low-throughput techniques such as nuclear magnetic resonance (NMR) and X-ray crystallography. More recent approaches have started to exploit biochemical reactions to perform high-throughput profiling of the RNA structure: Parallel Analysis of RNA Structure (PARS) distinguishes double- and single-stranded regions using the catalytic activity of two enzymes, RNase V1 (able to cut double-stranded nucleotides) and S1 (able to cut single-stranded nucleotides) ([@B3],[@B4]), while Selective 2΄-Hydroxyl Acylation analyzed by Primer Extension (SHAPE) ([@B5],[@B6]) employs highly reactive chemical probes such as 1M6, NMIA (SHAPE) and NAI-N~3~ (icSHAPE) to characterize RNA backbone flexibility. Another technique based on dimethyl sulfate (DMS) ([@B7]) is often used for *in vivo* probing of transcriptomes ([@B8],[@B9]). DMS experiments are of high quality due to the smaller size of the (CH~3~O)~2~SO~2~ probe, yet have low coverage, since the alkylating agent only reacts to adenine and cytosine.

Transcriptomic studies require intense experimental work that could be substantially reduced by using computational approaches. We built Computational Recognition of Secondary Structure (CROSS) to perform high-throughput predictions of transcript structure using the information contained in RNA sequences. The algorithm predicts the structural profile (single- and double-stranded state) of a transcript at single-nucleotide resolution using sequence information only and without sequence length restrictions.

We trained CROSS on data from high-throughput \[PARS: yeast and human transcriptomes ([@B3],[@B4]) and icSHAPE: mouse transcriptome ([@B5])\] and low-throughput \[SHAPE: HIV RNA ([@B10])\] experiments as well as high-quality NMR/X-ray structures ([@B11]). We did not use DMS experiments because they do not provide information on the structural state of all the nucleotides ([@B1],[@B5]). Each of the five models reflects the specificities of the experimental technique used to generate the data. Since each approach has practical limitations and a different range of applicability, we also evaluated different methods to integrate the five models into a single algorithm, *Global Score*, to provide a *consensus* prediction.

The core of CROSS is an artificial neural network yielding a propensity score ranging from −1 (bottom values; single-stranded RNA) to 1 (top values; double-stranded RNA). CROSS was designed to investigate large-scale data sets and to provide information that can be integrated in methods for prediction of RNA secondary structure ([@B12]) as well as interactions with other molecules ([@B13]).

MATERIALS AND METHODS {#SEC2}
=====================

CROSS architecture {#SEC2-1}
------------------
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Consensus models {#SEC2-2}
----------------

Since one technique might not be sufficient to capture structural properties of long transcripts ([@B14]), we evaluated different approaches to combine the five CROSS models (PARS-Human, PARS-Yeast, SHAPE-HIV, icSHAPE-Mouse and NMR/X-ray) into a *consensus* prediction. To this aim, we measured the performances of the models on an independent test set of 67 NMR/X-ray structures ([@B15]) for which SHAPE data are available (17 145 fragments in total), evaluating precision (PPV) and Area Under the ROC Curve (AUC; [Supplementary Data](#sup1){ref-type="supplementary-material"}). Consistently with the type of information contained in the training set, we observed the best performances for the NMR/X-ray model (PPV: 0.69; AUC: 0.64) followed by HIV-SHAPE (PPV: 0.64; AUC: 0.63). Comparing the scores of the five models, we did not find strong correlations ([Supplementary Data](#sup1){ref-type="supplementary-material"}), except for PARS-Human and PARS-Yeast (Pearson\'s correlation = 0.50) that were trained on data obtained with the same experimental techniques (Figure [1](#F1){ref-type="fig"}; [Supplementary Data](#sup1){ref-type="supplementary-material"}).

![(**A**) To build the Computational Recognition of Secondary Structure (CROSS) models we used experimental data from four transcriptome-wide studies (*H. sapiens, M. musculus, S. cerevisiae* and HIV-1) as well as NMR/X-ray structures ([@B3],[@B5],[@B4]--[@B11]). Each model was trained on one data set (PARS-Human, PARS-Yeast, icSHAPE-Mouse, SHAPE-HIV and NMR/X-ray) and tested on the others. (**B**) Performances increase from low- (median) to high-confidence (top and bottom 5%) values of the CROSS scores distribution ([Supplementary Data](#sup1){ref-type="supplementary-material"}). The plot illustrates the performances of the icSHAPE-Mouse model tested on the SHAPE-HIV data set. (**C**) High-confidence predictions: the arrows connect the training and testing sets along withrelative accuracies (cross-validation on training sets are marked with circular arrows). We used the same number of nucleotides with high (double-stranded) and low (single-stranded) propensity scores for comparison with experimental data. Negligible overlap exists between training and testing sets (Jaccard index \< 0.002 between each couple of sets analyzed; [Supplementary Data](#sup1){ref-type="supplementary-material"}).](gkw1094fig1){#F1}

*Z-Score* {#SEC2-3}
---------

We combined the five CROSS models into a *Z-Score* variable. For each nucleotide in the sequence, the *Z-Score* is computed using the mean of the individual scores and the associated standard deviation: the double-stranded propensity is proportional to the *Z-Score*. We used this method to predict the structural profile of the *Xist* non-coding RNA (17 900 nt) and found an AUC of 0.75 on data from DMS experiments ([@B16]).

*Global Score* {#SEC2-4}
--------------

We employed the scores of the five CROSS models to train a single classifier. The training set comprised 43 sequences (11 670 fragments) and the test set was composed of 24 transcripts (5 475 fragments; not in the training set of any of the CROSS models) ([@B15]). Among different classifiers the support vector machine with radial basis function kernel shows the best performances ([Supplementary Data](#sup1){ref-type="supplementary-material"}).

The *Z-Score* and *Global Score* predictions show a correlation of 0.85 (0.97 with a smoothing window of 200 nt) when applied to the *Xist* non-coding RNA (17 900 nt) ([Supplementary Data](#sup1){ref-type="supplementary-material"}). The high correlation indicates that the five models are assigned similar weights by *Global Score* and thus have similar performances. Since CROSS *Z-Score* and *Global Score* are correlated, we only provide *Global Score* on our webserver.

RNAstructure {#SEC2-5}
------------

We used *RNAstructure* with the *Fold* module and the *minimum free energy* flag to predict the best RNA secondary structure of each RNA sequence ([@B17],[@B18]). To mimic experimental constraints in the *RNAstructure* algorithm, CROSS Global scores were normalized to lie in the range of SHAPE reactivities: first the scores were multiplied by −1, then linearly mapped to \[0,1\]. Scores \>0.65 were then assigned a SHAPE reactivity of 1; scores \<0.35 were assigned a reactivity of 0; scores \>0.35 and \<0.65 were linearly mapped to (0,1). We used the *Partition* and *Probability Plot* (with *-text* flag) modules of *RNAstructure* to compute the AUC based on the probabilities ([@B17],[@B18]). We employed the package *Scorer* to calculate the positive predictive values (PPVs) and true positive rates (TPRs) for the specific structures.

Sequence patterns {#SEC2-6}
-----------------

We used DREME from the MEME suite (<http://meme-suite.org/doc/dreme.html>) to search for patterns in the positive and negative fragment sets ([@B19]). The flag *--n* was selected to specify a negative data set as comparison during the search of the motives.

RESULTS AND DISCUSSION {#SEC3}
======================

The CROSS algorithm {#SEC3-1}
-------------------

CROSS predicts the structural profile of an RNA sequence at single-nucleotide resolution and without sequence length restrictions. The algorithm is an artificial neural network with one hidden layer and two adaptive weight matrices to predict the structural state of a nucleotide considering its flanking residues (Materials and Methods: *CROSS architecture;*[Supplementary Data](#sup1){ref-type="supplementary-material"}: *Selection of the optimal window*). We built five independent models using data from SHAPE (Mouse and HIV transcriptomes ([@B5],[@B10]): icSHAPE-Mouse and SHAPE-HIV) and PARS experiments (Human and Yeast transcriptomes ([@B3],[@B4]): PARS-Human and PARS-Yeast) as well as data from NMR/X-ray studies (PDB database: NMR/X-ray) (Figure [1A](#F1){ref-type="fig"}). The training of each model was carried out on strong-signal sequences ([Supplementary Data](#sup1){ref-type="supplementary-material"}: *Data sets*) with the central nucleotide in either single-stranded (negative cases) or double-stranded (positive cases) configuration. Each model was then tested on all the other data sets. Negligible overlap exists between training and testing sets (Jaccard index \< 0.002 between each couple of sets analyzed; [Supplementary Data](#sup1){ref-type="supplementary-material"}).

From low- (top and bottom 50% of the CROSS score distribution) to high-confidence (top and bottom 5%) predictions, we observed an increase in the accuracies of our models, which indicates good ability to capture strong-signal regions. For instance, the accuracy of the icSHAPE-Mouse model applied to the SHAPE-HIV data set improves from 0.63 (low-confidence) to 0.81 (high-confidence; Figure [1B](#F1){ref-type="fig"}), and the same trend is found with respect to other data sets ([Supplementary Data](#sup1){ref-type="supplementary-material"}). High-confidence predictions of PARS-Human (training fragments: 26 444; testing fragments: 77 476) and icSHAPE-Mouse (711 480 training fragments, 35 516 testing fragments) models on all the other sets reach accuracies of 0.77 and 0.76, PPVs of 0.80 and 0.77, TPRs of 0.76 and 0.76 and true negative rates of 0.79 and 0.77, respectively (Figure [1C](#F1){ref-type="fig"}; [Supplementary Data](#sup1){ref-type="supplementary-material"}). As for PARS-Yeast, the accuracy, PPV and TPR are 0.64, 0.68 and 0.64, respectively. The model trained on NMR/X-ray data (29 428 training fragments, 77 176 testing fragments) shows an accuracy of 0.76, a PPV of 0.73 and a TPR of 0.79. SHAPE-HIV (fragments: 6 474 for training, 410 578 for testing) has an average accuracy, PPV and TPR of 0.66, 0.64 and 0.69.

We observed comparable cross-validation performances on the PARS datasets (area under the ROC curve AUC of 0.89 for PARS-Yeast applied to PARS-Human, and 0.90 for PARS-Human applied to PARS-Yeast), even though the experiments were carried out in different organisms and with slightly modified protocols, confirming the high quality of our predictions (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).

![Receiver Operating Characteristic (ROC) curves reveal significant cross-validation performances on the complete data sets of PARS-Human (left panel; area under the ROC curve (AUC) = 0.90) and PARS-Yeast (right panel; AUC = 0.89).](gkw1094fig2){#F2}

![Performances on complete data sets. Testing performances with AUC \> 0.70 are highlighted in bold (intra-set 5-fold cross-validations are in grey).](gkw1094fig3){#F3}

From low- (top and bottom 50% of the PARS score distribution) to high-confidence (top and bottom 1%) experimental values, we found a consistent increase in the performances of all models ([Supplementary Data](#sup1){ref-type="supplementary-material"}), thus providing strong evidence on the reliability of CROSS predictions. For instance, the SHAPE-HIV model predicts the whole PARS-Human data set with an AUC of 0.70 and the top and bottom 1% of the scores are with an AUC of 0.80 ([Supplementary Data](#sup1){ref-type="supplementary-material"}). We note that very negligible overlap exists between yeast and human fragment sets (overlap: 0.001%; Jaccard index: 0.001; [Supplementary Data](#sup1){ref-type="supplementary-material"}), which indicates that our method is not biased by specific sequences. On the same sets, approaches based on thermodynamic principles ([@B15],[@B18]) show lower performances (Yeast: accuracies in the range 0.72--0.74, Human: accuracies in the range 0.67--0.69) than CROSS (Yeast: 0.80 accuracy using PARS-Human model; Human: 0.81 accuracy using PARS-Yeast model; [Supplementary Data](#sup1){ref-type="supplementary-material"}), indicating that our method is particularly useful for predictions on high-throughput data sets.

The HIV-1 case: correlation between *in silico* and *in vitro* data {#SEC3-2}
-------------------------------------------------------------------

The model built on PARS-Human is able to predict SHAPE-HIV data with an AUC of 0.75 (Figure [4A](#F4){ref-type="fig"} and [B](#F4){ref-type="fig"}). Increasing the confidence threshold of SHAPE data (from \>0.5 for single-stranded, \<0.2 for double-stranded to \>1 for single-stranded and \<0.1 for double-stranded) improves CROSS performances to an AUC of 0.80 (Figure [4B](#F4){ref-type="fig"}). We compared experimental and predicted values on fragments of 200 nucleotides, reporting an average correlation of 0.60 (peak of 0.86 in the region 3 800--4 000) for the HIV transcriptome (Figure [4A](#F4){ref-type="fig"} and [C](#F4){ref-type="fig"}).

![(**A**) Example of the secondary structure profile of the HIV transcriptome (nucleotides 3 800--4 000) calculated with the PARS-Human model. CROSS predictions show a correlation of 0.86 with the experimental Selective 2΄-Hydroxyl Acylation analyzed by Primer Extension (SHAPE) profile. (**B**) ROC curves of CROSS-Human applied to HIV-SHAPE data. The performances increase when selecting a high confidence threshold (\>1 for single-stranded; \<0.1 for double-stranded) on SHAPE experimental data. (**C**) Pearson correlations between experimental and predicted data for the HIV transcriptome calculated on 200-nucleotide regions using a smoothing window of 7 nucleotides. The average correlation is 0.6.](gkw1094fig4){#F4}

Recognition of complex patterns {#SEC3-3}
-------------------------------

CROSS is able to identify sequence patterns that cannot be captured by a position weight matrix approach. We searched the positive and negative fragment sets extracted from icSHAPE-Mouse and PARS-Human data for sequence patterns ([Supplementary Data](#sup1){ref-type="supplementary-material"}) using DREME (Materials and Methods: *Sequence patterns*) ([@B19]). In icSHAPE-Mouse sequences, the G/GC/ACGU/GC motif occurs with frequencies of 63% and 43% in the positive (556 645 fragments) and negative (355 740 fragments) sets ([Supplementary Data](#sup1){ref-type="supplementary-material"}), indicating poor discrimination. As for PARS-Human, the top motif in the positive fragment set GCU/GC/AG/G (71% frequency) is also non-specific (frequency of 47% in the negative set). This observation indicates that the neural network approach is particularly suitable to identifying complex patterns in biological sequences, which is key to discover trends in large data sets ([@B20]). We also note that CROSS models are sensitive to single point mutations: the signal drops progressively upon insertion of random mutations in the original sequences (PARS-Yeast; [Supplementary Data](#sup1){ref-type="supplementary-material"}). As expected, mutations in the central position of the fragment produce the most dramatic reduction in the predictive power of the method ([Supplementary Data](#sup1){ref-type="supplementary-material"}).

The consensus model *Global Score* {#SEC3-4}
----------------------------------

The consensus model *Global Score* was trained and tested on independent sets of NMR/X-ray structures (11 670 training fragments, 5 475 testing fragments; [Supplementary Data](#sup1){ref-type="supplementary-material"}: *Data sets;* Materials and Methods: *Consensus models*) ([@B15],[@B21]). In the testing phase, single and double-stranded nucleotides were recognized with an AUC of 0.72 and a PPV of 0.74. Comparing the structures with experimental SHAPE data, we observed similar performances (AUC of 0.76 and PPV of 0.76 on the same data set; Figure [5](#F5){ref-type="fig"}). As PARS-Yeast and PARS-Human models show a 0.5 correlation ([Supplementary Data](#sup1){ref-type="supplementary-material"}), we decided to train the method without PARS-Yeast or PARS-Human. The procedure reduces *Global Score* performances (without PARS-Yeast: AUC from 0.72 to 0.65, PPV from 0.74 to 0.68; without PARS-Human AUC from 0.72 to 0.66, PPV from 0.74 to 0.65), which indicates that the methods should be used together.

![Performance comparison of SHAPE data and CROSS predictions (*Global Score*) on sequences with available structural information derived from NMR/X-ray data ([@B21]). The performances are calculated on 24 RNAs that were not employed for training ([@B15]). The precision is measured at Youden\'s cut-off.](gkw1094fig5){#F5}

*Global score* as experimental constraint for thermodynamic approaches {#SEC3-5}
----------------------------------------------------------------------

As previously done with experimental SHAPE data, we used *Global Score* as a constraint in *RNAstructure* ([@B12]). On the test set ([@B15]), *Global Score* increases the PPV of *RNAstructure* from 0.68 to 0.72, with remarkable improvements in 13 cases (from 0.44 to 0.72; [Supplementary Data](#sup1){ref-type="supplementary-material"}; Figure [6A](#F6){ref-type="fig"} and [C](#F6){ref-type="fig"}; [Supplementary Data](#sup1){ref-type="supplementary-material"}; [Supplementary Data](#sup1){ref-type="supplementary-material"}: *RNAstructure*), and decreases the PPV in three cases for which real SHAPE data does not improve performances (PPV: Group II intron *O. iheyensis*: 0.97 with *RNAstructure* versus 0.84 with SHAPE data; HIV-1 5΄ pseudoknot domain: 0.62 versus 0.55; SARS corona virus pseudoknot: 0.90 versus 0.75). To assess to what extent *Global Score* improves *RNAstructure* ([Supplementary Data](#sup1){ref-type="supplementary-material"}), we randomized the *Global Score* input and observed an overall PPV decrease to 0.64. Moreover, using the partition function computed with *RNAstructure*, we calculated the AUC for each structure with and without CROSS constraints and observed an improvement from 0.81 to 0.86 when CROSS is integrated in the algorithm (Figure [6B](#F6){ref-type="fig"}). On the test set ([@B15]), we found a similar trend using *RNAfold* ([@B15]) (the PPV increases from 0.67 to 0.70 using *Global Score* and the AUC remains at 0.85).

![(**A** and **B**) Performances of *RNAstructure* ([@B12],[@B18]) without constraints and using either CROSS *Global Score* predictions or SHAPE data. Precision (PPV) and area under the ROC curve (AUC) increase when CROSS predictions are employed as constraints in *RNAstructure*, indicating a global improvement of predictive power. Randomizing the CROSS signal (in the range of SHAPE data) decreases the performances of *RNAstructure*. (**C**) Prediction of the structure of the P546 domain bI3 group I intron using CROSS predictions as constraints to *RNAstructure*: Sensitivity (TPR) (without CROSS: TPR = 0.43; with CROSS: TPR = 0.63) and precision (without CROSS: PPV = 0.44; with CROSS: PPV = 0.71) are reported.](gkw1094fig6){#F6}

The X*ist* case and comparison with DMS experiments {#SEC3-6}
---------------------------------------------------

Due to the complexity of the configuration space, the structural profile of sequences \>1 000--1 500 nucleotides is extremely difficult to predict with thermodynamic approaches ([@B22]), which makes CROSS a valid alternative to study long non-coding RNAs ([@B23]). To illustrate CROSS performances on large RNAs, we predicted the structural profile of murine *Xist* non-coding RNA (17 900 nt) using the *consensus* of our five models (Materials and Methods: *Consensus models*; Figure [7A](#F7){ref-type="fig"}). *Xist* was analyzed using DMS probing ([@B16]), an independent technique not used in the training of CROSS (the transcript was not present in any training set of CROSS). Using the top and bottom 10% of the experimental DMS data on *Xist* profile (3 580 fragments removing regions with unreliable scores in Rep B) the Z-Score shows an AUC of 0.75 (Figure [7A](#F7){ref-type="fig"}, right corner). In agreement with DMS experiments ([@B16]), CROSS identifies the structural elements associated with repetitive regions Rep A, B and F and resolves their internal structures with correlations of 0.35, 0.46 and 0.75, respectively (see [Supplementary Data](#sup1){ref-type="supplementary-material"}). Although the method slightly overestimates the structural content of Rep E, it is able to accurately predict its profile (correlation of 0.63, [Supplementary Data](#sup1){ref-type="supplementary-material"}). While the sequences of Rep A and B are conserved across species and show a high degree of structural content, the 3΄ region of *Xist* is variable ([@B24]) and predicted by CROSS to be more single-stranded.

![(**A**) CROSS *Z-Score consensus* prediction of the secondary structure profile of murine *Xist* long non-coding RNA (a 200 nt window is employed for smoothing). Structured regions, in correspondence to known repetitive domains (Rep A, B and F), are highlighted and the correlations with dimethyl sulfate (DMS) data ([@B16]) are reported on top. A detailed view of the CROSS and DMS profiles for Rep A, B, F and E is provided in [Supplementary Data](#sup1){ref-type="supplementary-material"}. We note that Rep B contains regions with insufficient sequencing data to determine DMS reactivity ([@B16]) that were excluded from the analysis. Our predictions indicate lower structural content at 3΄, in line with previous reports indicating poor sequence conservation (only Rep A and B are highly conserved) ([@B24]). The ROC curve of the *Z-Score* predictions on high-confidence DMS data (10% top and bottom nucleotides, 3 580 fragments) is reported in the corner (AUC 0.75). (**B**) Predictions of human coding DNA sequences (CDSs), untranslated regions (UTRs) and long-intergenic non-coding RNA (lincRNA) (ENSEMBL version 82; total number of transcripts: 50 000; 14 000 lincRNA isoforms). We predict that the UTRs are more structured than the CDSs, in agreement with previous studies (*P*-value \< 2.2e-16, Kolmogorov--Smirnov) ([@B1]). For each set we show a known example \[the APP 5΄ UTR is more structured, as shown in previous studies ([@B27]); SERPINE3 has a structured CDS in agreement with PARS data ([@B4]); *Xist* structural content is in agreement with DMSdata ([@B16])\].](gkw1094fig7){#F7}

Structural differences in human CDS, UTRs and lincRNAs {#SEC3-7}
------------------------------------------------------

We employed CROSS to analyze the structural differences between human coding DNA sequences (CDSs), untranslated regions (UTRs) (total of 217 000 non-redundant sequences each with 3΄ and 5΄ UTRs; ENSEMBL 82) and long intergenic non-coding transcripts (14 000 non-redundant sequences; ENSEMBL 82; [Supplementary Data](#sup1){ref-type="supplementary-material"}; Figure [7B](#F7){ref-type="fig"}). In agreement with previous evidence ([@B1]), we predict that UTRs are more structured than CDSs (*P*-value \< 2.2e-16; Kolmogorov--Smirnov). Long intergenic non-coding transcripts (see [Supplementary Data](#sup1){ref-type="supplementary-material"}: *Long intergenic non-coding RNAs*) are found to be less structured, as reported in other studies ([@B25]) (*P*-value \< 2.2e-16; Kolmogorov--Smirnov). Indeed, long non-coding RNAs have complex regulatory abilities and their structure could be more flexible and less structured to provide a wide range of interactions ([@B26]). In agreement with previous data ([@B27]), we also observe that the 5΄ UTR of the amyloid precursor protein APP transcript is highly structured (\>65% double-stranded). Similarly, the mRNA of serpin peptidase inhibitor SERPINE3 is predicted to be highly structured (\>55%), as reported in PARS screenings ([@B4]). We predict that 45% of *Xist* is structured in domains, as revealed by DMS profiling ([@B16]).

CONCLUSION {#SEC4}
==========

The study of large transcripts requires intense experimental work that could be substantially reduced by using computational approaches to characterize their structural features ([@B16]). Methods based on thermodynamic principles ([@B18],[@B28]) can be employed for RNAs \< 1 000--1 500 nucleotides and do not work for larger molecules because of the complexity of the configuration space ([@B22]). In our approach, we use local sequence properties of RNAs, which is key to perform fast high-throughput profiling of sequences, since the computational load scales linearly with the sequence length. Therefore, CROSS allows the prediction of the structural profile without sequence length restrictions.

We built CROSS using data from SHAPE ([@B5],[@B6]) and PARS ([@B3],[@B4]) studies as well as NMR/X-ray experiments. Models based on PARS and icSHAPE experiments show the highest predictive power with an average accuracy of 0.77 and 0.76, and a positive predictive value PPV of 0.8 and 0.77. The different algorithms can be used independently or combined together to obtain insights into the secondary structure of a transcript. Since each technique has its specificities and biases, the combination of multiple approaches is recommendable to achieve a better understanding of structural properties ([@B14]).

On high-throughput experimental data sets CROSS outperforms *RNAstructure* ([@B18]) and *RNAfold* ([@B15]) (CROSS: accuracy of 0.80 for PARS-Yeast and 0.81 for PARS-Human; *RNAstructure* and *RNAfold*: 0.72--0.74 for PARS-Yeast, 0.67--0.69 for PARS-Human). Yet, previous studies indicate that thermodynamic methods have a higher predictive power when the information derived from SHAPE experiments is integrated ([@B12]). Comparing SHAPE experiments and CROSS predictions on RNA molecules for which NMR/X-ray data are available ([@B15]), we found similar performances with an average precision of 0.74 (CROSS) and 0.76 (SHAPE), and an area under the receiver operating characteristics of 0.72 (CROSS) and 0.76 (SHAPE). Thus, CROSS can be considered an *in silico* alternative to SHAPE experiments ([@B5],[@B6]) and its integration in *RNAstructure* ([@B17],[@B18]) shows performances (PPV: 0.72; AUC: 0.85) that are comparable to those achieved using real SHAPE data (PPV: 0.80, AUC: 0.88).

Since CROSS is fast (less than 2 min to profile a transcript of 20 000 nucleotides), it can be used for high-throughput predictions of the RNA secondary structure. We used CROSS to investigate profiles of sequences taken from CDSs as well as untranslated regions UTRs \> 200 000 isoforms (calculated in \<72 h) reporting a structural content that is compatible with what is available in literature ([@B1]). We also studied the structural profile of *Xist* and identified specific regions in agreement with DMS experiments \[correlations of 0.63 and 0.75 for Rep E and Rep F ([@B16])\].

Our predictions of structural features will facilitate the design of experimental studies on long transcripts by revealing the structural state of their regions. The calculations can be employed to shed light on the evolution of RNA molecules and on their interactions with other molecules. Our approach can be also exploited to improve the predictive power of algorithms such as for instance *cat*RAPID, which computes the interaction propensity of protein and RNA molecules ([@B29]). We envisage that the combination of CROSS with thermodynamics-based approaches will be the key ingredient to improve predictions of RNA structure.
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